Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
es PLC - London-based medical cannabis pharmaceutical firm - On Wednesday, said intends to withdraw its shares from tr ...
Apollon Formularies PLC on Tuesday said that a peer-reviewed publication publicised successful cancer cell-killing re ...
es PLC - London-based medical cannabis pharmaceutical firm - Says concludes due diligence with Sproutly Canada, a supp ...
The following is a round-up of earnings by London-listed companies, issued last week and not separately reported by A ...
es PLC - London-based medical cannabis pharmaceutical firm - Signs exclusive license agreement with PureCann Pty Ltd, ...
es PLC - London-based medical cannabis pharmaceutical firm - Reports revenue in 2022 rose 45% to GBP286,144 from GBP19 ...
Apollon Formularies PLC on Tuesday said it has agreed a 28-day extension to complete final due diligence in order to ...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
